• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ELECSYS TSH ASSAY; RADIOIMMUNOASSAY, THYROID-STIMULATING HORMONE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ELECSYS TSH ASSAY; RADIOIMMUNOASSAY, THYROID-STIMULATING HORMONE Back to Search Results
Model Number TSH
Device Problem Non Reproducible Results (4029)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 12/12/2019
Event Type  malfunction  
Manufacturer Narrative
This event occurred in (b)(6).(b)(4).
 
Event Description
The initial reporter stated they received discrepant results for two samples from the same patient tested with thyroid assays on the cobas 6000 e 601 module and a cobas 8000 e 602 module used for investigation.One sample labeled "sample 2" had discrepant values for elecsys tsh assay, elecsys ft3 iii, and the elecsys ft4 iii assay when tested on both systems.The other sample labeled "sample 1" had discrepant values for tsh and the elecsys tsh assay version 2 (tshv2) when tested on the e 602 system.The values measured at the customer site were reported outside of the laboratory to a physician.This medwatch will apply to the tsh assay.Please refer to the medwatch with patient identifier (b)(4) for information related to the tshv2 assay, refer to the medwatch with patient identifier (b)(4) for information related to the ft3 assay, and refer to the medwatch with patient identifier (b)(4) for information related to the ft4 assay.Refer to the attachment for all patient data.Values highlighted in yellow are erroneous.The sample labeled "sample 2" was measured at the customer site on (b)(6)2019.The sample labeled as "sample 1" was collected and tested on a different date at a different time, but this date/time is unknown.The samples were provided for investigation and tested on the e 602 analyzer.Tsh, ft3, and ft4 were tested on the e 602 for sample 2 on (b)(6) 2020.All testing for sample 1 was performed on the e 602 analyzer on (b)(6) 2020.For investigations, the sample was also tested with tsh on the e 602 analyzer before and after treatment with a heterophilic antibody blocking tube (hbt).The serial number of the customer's e 601 analyzer is (b)(4).The serial number of the e 602 analyzer used for investigation is (b)(4).Tsh reagent lot number 429091, with an expiration date of april 2020 was used on this analyzer.
 
Manufacturer Narrative
Upon further investigation of the patient samples, the customer's results could be duplicated.It was determined there were no interfering factors in the sample.The biotin concentrations in both samples were measured and concentrations of 193 ng/ml and 198 ng/ml were measured.The measured biotin concentration in both samples is above the threshold concentration of the tsh version 1 assay (of 25 ng/ml) and below the threshold concentration of the tsh version 2 assay (of 1200 ng/ml), as specified in the method sheets of both assay versions.This explains the different tsh values of both tsh assay versions; the value of the tsh version 2 assay is considered as correct.
 
Manufacturer Narrative
The patient had the following relevant test data: on (b)(6) 2017, the patient had a tsh result of 1.890 ¿iu/ml, a ft4 result of 1.46 ng/dl, and a ft3 result of 3.30 pg/ml.On (b)(6) 2017, the patient had a tsh result of 1.634 ¿iu/ml, a ft4 result of 1.51 ng/dl, and a ft3 result of 3.47 pg/ml.On (b)(6) 2018, the patient had a tsh result of 0.879 ¿iu/ml, a ft4 result of 1.24 ng/dl, and a ft3 result of 2.29 pg/ml.On (b)(6) 2018, the patient had a tsh result of 1.267 ¿iu/ml, a ft4 result of 1.32 ng/dl, and a ft3 result of 2.83 pg/ml.On (b)(6) 2018, the patient had a tsh result of 0.126 ¿iu/ml, a ft4 result of 2.81 ng/dl, and a ft3 result of 4.06 pg/ml.On (b)(6) 2019, the patient had a tsh result of 0.118 ¿iu/ml, a ft4 result of 2.00 ng/dl, and a ft3 result of 4.11 pg/ml.On (b)(6) 2019, the patient had a tsh result of 0.094 ¿iu/ml, a ft4 result of 1.77 ng/dl, and a ft3 result of 3.40 pg/ml.On (b)(6) 2020, the patient had a tsh result of 0.117 ¿iu/ml, a ft4 result of 1.82 ng/dl, and a ft3 result of 3.79 pg/ml.On (b)(6) 2020, the patient had a tsh result of 0.091 ¿iu/ml, a ft4 result of 1.70 ng/dl, and a ft3 result of 3.15 pg/ml.On (b)(6) 2020, the patient had a tsh result of 0.146 ¿iu/ml, a ft4 result of 1.70 ng/dl, and a ft3 result of 3.72 pg/ml.Medwatch field d11 has been updated.- attachment: [pt-43256_pt-43257_pt-43258_pt-43259.Pdf].
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELECSYS TSH ASSAY
Type of Device
RADIOIMMUNOASSAY, THYROID-STIMULATING HORMONE
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
MDR Report Key9745832
MDR Text Key220300722
Report Number1823260-2020-00534
Device Sequence Number1
Product Code JLW
Combination Product (y/n)N
PMA/PMN Number
K961491
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup,Followup
Report Date 04/03/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberTSH
Device Catalogue Number11731459122
Device Lot Number429091
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received 02/06/2020
Initial Date FDA Received02/24/2020
Supplement Dates Manufacturer Received02/06/2020
02/06/2020
Supplement Dates FDA Received03/13/2020
04/03/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
SEE ATTACHMENT FOR PATIENT MEDICATIONS.
Patient Age7 YR
-
-